|
Volumn 158, Issue 10, 2001, Pages 1728-1730
|
Pregnancy outcome following gestational exposure to venlafaxine: A multicenter prospective controlled study
a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DEXTROMETHORPHAN;
FLUOXETINE;
FLUVOXAMINE;
LOPERAMIDE;
PAROXETINE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
SUMATRIPTAN;
VENLAFAXINE;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONGENITAL MALFORMATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DRUG SAFETY;
FEMALE;
FETUS OUTCOME;
HUMAN;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
PRENATAL DRUG EXPOSURE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SPONTANEOUS ABORTION;
TERATOGENICITY;
ABNORMALITIES, DRUG-INDUCED;
ABORTION, SPONTANEOUS;
ABORTION, THERAPEUTIC;
BIRTH WEIGHT;
CYCLOHEXANOLS;
DEPRESSIVE DISORDER;
FEMALE;
GESTATIONAL AGE;
HUMANS;
INFANT, NEWBORN;
MATERNAL EXPOSURE;
MATERNAL-FETAL EXCHANGE;
PREGNANCY;
PREGNANCY COMPLICATIONS;
PREGNANCY OUTCOME;
PREGNANCY TRIMESTER, FIRST;
PROSPECTIVE STUDIES;
RISK FACTORS;
SEROTONIN UPTAKE INHIBITORS;
SMOKING;
|
EID: 0034813415
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.158.10.1728 Document Type: Article |
Times cited : (211)
|
References (17)
|